Multimodal Non-Surgical Treatments of Aggressive Pituitary Tumors

Up to 35% of aggressive pituitary tumors recur and significantly affect mortality and quality of life. Management can be challenging and often requires multimodal treatment. Current treatment options, including surgery, conventional medical therapies such as dopamine agonists, somatostatin receptor...

Descripción completa

Detalles Bibliográficos
Autores principales: Nakano-Tateno, Tae, Lau, Kheng Joe, Wang, Justin, McMahon, Cailin, Kawakami, Yasuhiko, Tateno, Toru, Araki, Takako
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8033019/
https://www.ncbi.nlm.nih.gov/pubmed/33841328
http://dx.doi.org/10.3389/fendo.2021.624686

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8033019/
https://www.ncbi.nlm.nih.gov/pubmed/33841328
http://dx.doi.org/10.3389/fendo.2021.624686

Ejemplares similares